05 May May 5th, 2018 Istabul, Turkey and Pully, Switzerland: Nobel Ilac and CarthaGenetics® announce collaboration for rare diseases in North Africa area.
Nobel Ilac is a full-cycle Turkish pharmaceutical company founded in 1964, producing world-class pharmaceuticals for human health. Nobel Ilac provides a global presence of outstanding, reliable and accessible products for human health.
CarthaGenetics® is focusing on finding innovative early patients access to medicines for supplying the unmet needs and is a pioneer with having the broadest experience in the field of rare diseases, gene therapies and biosimilars.
Nobel Ilac and CarthaGenetics® announce the collaboration for rare diseases in North Africa area.